PK/PD of BIWH 3 in Healthy Duffy Positive vs. Negative Volunteers

Phase 1, randomised, double-blind trial in peripheral arterial disease (PAD) comparing BIWH 3 with Placebo (2 arms). Primary endpoints: Area under the plasma concentration-time curve extrapolated to infinity up to 14 days, Area under the plasma concentration-time curve up to the last quantifiable plasma concentration up to 14 days and 1 more. Started Jun 2003; status: completed.